Tissue microarray (TMA) technology is accelerating the development of current investigations including molecular in situ analysis and its integration with clinical and pathological data. On a single slide, various tissue samples from different people are examined for protein expression using tissue microarrays. For all kinds of tissue-based research, tissue microarray is currently frequently employed, especially in cancer. They provide a variety of applications for research and quality assurance. The development of fundamental research discoveries into therapeutic applications has been significantly accelerated using tissue microarray. Tissue microarrays have shown to be reliable in confirming known relationships between the expression of certain tumour receptors and their associated known tissue changes.

Abeomics is involved in the tissue microarray technology, which aids scientists and researchers in doing their experiments in an expert manner.